Supporting the role of NPC1 in invasion, 5 μM U18666A treatment of ErbB2 positive ovarian cancer organoids, whose invasive growth is dependent on full-length ErbB2 [29], resulted in complete inhibition of invasive growth (Fig. 6D). This evidence concerns the gene ERBB2 and ovarian cancer.